Background: Knowledge about immunological features and growth characteristi
cs of palpebral (ocular) basal cell carcinomas (BCCs) is limited. In partic
ular, it is unclear whether ocular BCC represents in this regard a special
BCC entity or not. Methods: Twenty BCCs of the lid area (ocular BCCs) were
investigated immunohistologically using monoclonal antibodies against CD4,
CDs, CD45Ro, CD50, CD68, HECA-452, Ki67 (MIB1), and the p53 epitope. For co
mparison, nine BCCs excised distant from the eye (non-ocular BCCs) were eva
luated. Results: In BCCs the distribution of the immunocompetent cells inve
stigated is markedly irregular. These cells are localized mainly around BCC
islands. Only a few of them invade tumour cell aggregates. The CD4:CD8 rat
io as detected by immunohistochemistry is >1 in 82% of ocular BCCs and in 8
8% of nonocular BCCs. Often there are dense infiltrations of CD68+ cells (m
acrophages) and HECA-452+ cells adjacent to tumour cell aggregates. The gro
wth fraction [percentage of proliferating (Ki67+/MIB1+) cells] varies from
0% to more than 30%. Proliferative activity is enhanced at the invasion fro
nt. Additionally, the amount of p53+ cells differs considerably among the B
CCs. Conclusions: CD4+ T cells seem to be the most important cell populatio
n for BCC immunosurveillance, offering the chance for conservative interfer
on therapy. The role of CD68+ and HECA-452+ cells has to be further elucida
ted. In many tumours the large amount of proliferating cells contrasts to t
he usually slow growth of BCCs, indicating strong apoptotic processes. The
results can be regarded only as semiquantitative. So far, ocular and nonocu
lar BCCs exhibit no essential differences regarding immunocompetent cell in
filtration and growth characteristics. According to this, palpebral BCCs ar
e "normal" BCCs and not a special BCC variant. Therefore, results from derm
atological research concerning BCC can be extended without limitations to t
heir counterparts in the lid area.